Colonel Yalon Farhi Joins MicroVision’s Board of Directors

REDMOND, Wash.--(BUSINESS WIRE)-- MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced that Colonel (IDF res.) Yalon Farhi has joined its board of directors. Colonel Farhi’s election expands the number of MicroVision board members to eight.

Colonel Farhi’s career encompasses a wealth of experience that spans serving in the Israeli Defense Forces (IDF), lecturing at Bnei David Institute since 1998, working for an Israeli non-government organization as a lead administrative manager and fundraiser for nearly 20 years and operating a successful business for over 30 years. Colonel Farhi also has acted as a consultant to multiple security companies and is currently a director at DarioHealth Corp. (NASDAQ: DRIO).

“Colonel Farhi will bring new perspectives and insights to the MicroVision board based on his broad, international experience,” said Brian Turner, Chairman and Independent Director at MicroVision. “We look forward to having his voice and counsel as we progress MicroVision’s business and look to apply PicoP® scanning technology to emerging markets such as 3D sensing and augmented reality.”

“I am pleased to be joining the MicroVision board at this pivotal time in the company’s history. The company’s technology, the breadth of its patent portfolio and its potential to enable multiple applications is impressive,” said Colonel Farhi. “I look forward to sharing my experience with management and my fellow board members to assist the company with execution of its business plan.”

Colonel Farhi is a graduate in Education Studies from Moreshet Yaacov College in Jerusalem and military study in the Israeli Defense Forces.

About MicroVision

MicroVision is the creator of PicoP® scanning technology, an ultra-miniature laser projection and sensing solution based on the laser beam scanning methodology pioneered by the company. MicroVision's platform approach for this advanced display and sensing solution means that it can be adapted to a wide array of applications and form factors. It is an advanced solution for a rapidly evolving, always-on world. Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Wash.

For more information, visit the company’s website at, on Facebook at or follow MicroVision on Twitter at @MicroVision.

MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including those relating to future product and product applications are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP® scanning technology may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

MicroVision, Inc.
Dawn Goetter, 425-882-6629 (investors)
Nicole Cobuzio, 732-212-0823 ext. 102 (media)

Source: MicroVision, Inc